Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.45 HKD | +3.59% | +11.74% | -17.62% |
04-30 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
04-29 | Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.43B | - | |||||
109B | ||||||
105B | ||||||
22.25B | - | |||||
22.09B | - | |||||
18.68B |